• Publications
  • Influence
Skin Collagen Changes in Postmenopausal Women Receiving Different Regimens of Estrogen Therapy
Collagen is a widespread body constituent that is affected by estrogen status in women. Its decrease after menopause can be prevented and/or restored by estrogen treatment. We explored the effect ofExpand
  • 180
  • 9
Long‐term effects of the menopause and sex hormones on skin thickness
Summary. Skin collagen content and skin thickness in a group of postmenopausal women who had been treated with sex hormone implants were compared with those in an untreated group of similar women.Expand
  • 227
  • 6
A Study of the Decrease of Skin Collagen Content, Skin Thickness, and Bone Mass in the Postmenopausal Woman
The skin collagen content, skin thickness, metacarpal index, and forearm bone mineral content in postmenopausal women showed a similar decline of between 1–2% per year after the menopause. All fourExpand
  • 160
  • 4
The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: a model for the premenstrual syndrome
Summary. The influence of norethisterone on mood and behaviour was investigated in prospective placebo‐controlled study in 58 postmenopausal hysterectomized women who were being treated withExpand
  • 204
  • 3
Treatment of the premenstrual syndrome by subcutaneous estradiol implants and cyclical oral norethisterone: placebo controlled study.
The hypothesis that the many non-specific changes normally associated with cyclical ovarian activity are the primary aetiological factors in the premenstrual syndrome was tested by suppressingExpand
  • 158
  • 3
  • PDF
Hormone replacement therapy and the skin.
Estrogens have a profound influence on skin. The hypoestrogenism occurring after the menopause leads to measured deterioration in the skin. Estrogen receptors have been identified in the skin and theExpand
  • 152
  • 3
EMAS position statement: Vitamin D and postmenopausal health.
INTRODUCTION There is emerging evidence on the widespread tissue effects of vitamin D. AIMS To formulate a position statement on the role of vitamin D in postmenopausal women. MATERIALS ANDExpand
  • 90
  • 3
  • PDF
TNFRSF11B gene variants and bone mineral density in postmenopausal women in Malta.
UNLABELLED A number of polymorphisms in various genes have been identified and associated with bone mineral density (BMD) and with an increased risk of osteoporosis. OBJECTIVE In this study, threeExpand
  • 48
  • 3
  • PDF
EMAS position statement: Managing the menopause in the context of coronary heart disease.
INTRODUCTION Cardiovascular disease (CVD) including coronary heart disease (CHD) and stroke is the most common cause of female death. Premenopausal CHD is very rare but when women enter the menopauseExpand
  • 47
  • 3
EMAS position statement: Managing menopausal women with a personal or family history of VTE.
INTRODUCTION Venous thromboembolism (VTE), including deep venous thrombosis (DVT) and pulmonary embolism (PE), is a serious cardiovascular event whose incidence rises with increasing age. AIMS ToExpand
  • 33
  • 3